Total Payments
$938.05
2023 Payments
$290.04
Companies
12
Transactions
34
Payment Breakdown by Category
Food & Beverage$892.55 (95.1%)
Gifts$45.50 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $892.55 | 33 | 95.1% |
| Gift | $45.50 | 1 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $268.35 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $131.69 | 4 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $111.04 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $108.40 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $64.85 | 3 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $54.73 | 2 | $0 (2021) |
| Chiesi USA, Inc. | $45.50 | 1 | $0 (2021) |
| Novo Nordisk Inc | $40.92 | 2 | $0 (2021) |
| ABBVIE INC. | $38.00 | 2 | $0 (2023) |
| PBG PUERTO RICO LLC | $27.62 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $290.04 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($89.64) |
| 2022 | $367.36 | 12 | Merck Sharp & Dohme LLC ($138.21) |
| 2021 | $160.35 | 8 | Chiesi USA, Inc. ($45.50) |
| 2020 | $51.73 | 2 | Biohaven Pharmaceuticals, Inc. ($29.27) |
| 2019 | $68.57 | 3 | Janssen Pharmaceuticals, Inc ($52.78) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $55.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/17/2023 | Merck Sharp & Dohme LLC | VAXNEUVANCE (Biological) | Food and Beverage | In-kind items and services | $54.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/05/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/28/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: VIROLOGY | ||||||
| 03/23/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $60.47 | General |
| Category: DIABETES | ||||||
| 03/03/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| 02/24/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PAH | ||||||
| 02/14/2023 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $95.25 | General |
| Category: Hematology | ||||||
| 10/25/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/22/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: VIROLOGY | ||||||
| 09/14/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/09/2022 | Novartis Pharmaceuticals Corporation | ADAKVEO (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: HEMATOLOGY | ||||||
| 08/18/2022 | Merck Sharp & Dohme LLC | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $83.96 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/05/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| Category: Cardiovascular | ||||||
| 06/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: DIABETES | ||||||
| 06/15/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/06/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.95 | General |
| Category: Cardiovascular | ||||||
| 02/16/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: DIABETES | ||||||
| 12/14/2021 | PBG PUERTO RICO LLC | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/02/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Diabetes | ||||||
| 09/10/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: PRIMARY CARE | ||||||
| 08/24/2021 | Merck Sharp & Dohme Corporation | RECARBRIO (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: INFECTIOUS DISEASE | ||||||
About Dr. Kyomara Hernandez Moya, MD
Dr. Kyomara Hernandez Moya, MD is a Internal Medicine healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1780100834.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyomara Hernandez Moya, MD has received a total of $938.05 in payments from pharmaceutical and medical device companies, with $290.04 received in 2023. These payments were reported across 34 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($892.55).
Ad
Practice Information
- Specialty Internal Medicine
- Location San Juan, PR
- Active Since 08/21/2017
- Last Updated 10/22/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780100834
Products in Payments
- Adempas (Drug) $111.04
- RECARBRIO (Drug) $111.01
- JARDIANCE (Drug) $102.52
- ZERBAXA (Drug) $87.06
- XARELTO (Drug) $80.62
- ELIQUIS (Drug) $57.90
- NURTEC ODT (Drug) $54.73
- VAXNEUVANCE (Biological) $54.02
- CLEVIPREX (Drug) $45.50
- MAVYRET (Drug) $38.00
- OFEV (Drug) $29.17
- INVOKANA (Drug) $27.78
- TYVASO (Drug) $25.00
- Ozempic (Drug) $22.46
- ADAKVEO (Biological) $21.95
- RYBELSUS (Drug) $18.46
- SOMAVERT (Drug) $14.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Juan
Eric Carro Jimenez, Md, MD
Internal Medicine — Payments: $603,965
Internal Medicine $603,965
Dr. Alexis Cruz-Chacon, Md, MD
Internal Medicine — Payments: $486,831
Internal Medicine $486,831
Ricardo Fernandez, Md, MD
Internal Medicine — Payments: $419,840
Internal Medicine $419,840
Cristina Ramos, M.d, M.D
Internal Medicine — Payments: $415,435
Internal Medicine $415,435
Mirelis Acosta, M.d, M.D
Internal Medicine — Payments: $229,288
Internal Medicine $229,288
Cristian Rodriguez Arocho, Md, MD
Internal Medicine — Payments: $187,448
Internal Medicine $187,448